Long-Term OL Study of [S,S]-RBX in Patients With Fibromyalgia

This study has been terminated.

( This study has been terminated early as the esreboxetine development program is being discontinued. There are no safety or efficacy concerns. )

Study NCT00607256 Information provided by Pfizer

First Received: January 23, 2008 Last Updated: March 17, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	June 2009
Estimated Primary Completion Date:	June 2009 (Final data collection date for primary outcome measure)